Compounding pharmacies are not regulated as closely as drug manufacturers, and their products are not subject to FDA approval. A national shortage of many drugs has forced doctors to seek custom-made alternatives from compounding pharmacies.
New England Compounding Center said in a statement Thursday that despite the FDA warning, ‘‘there is no indication of any potential issues with other products.’’ It called the deaths and illnesses tragic and added: ‘‘The thoughts and prayers of everyone employed by NECC are with those who have been affected.’’
Associated Press writers Travis Loller in Nashville, Jay Lindsay in Boston, Randall Chase in Wilmington, Del., and AP chief medical writer Marilynn Marchione in Milwaukee contributed to this story.
Recalled list: http://www.fda.gov/Drugs/DrugSafety/ucm322752.htm